Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Developments in Biological Standardization
|
January 1, 1979
Testing for potential thrombogenicity of prothrombin complex concentrates
T J Snape
Developments in Biological Standardization
|
January 1, 1987
Quality control in the development of coagulation factor concentrates
T J Snape
Current Medicinal Chemistry
|
July 27, 2012
2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity
S Lal, T J Snape
Vox Sanguinis
|
January 1, 1980
Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield
R T Wensley, T J Snape
British Journal of Haematology
|
August 1, 1975
A five year experience of the use of factor IX type DE(I) concentrate for the treatment of Christmas disease of Oxford
J L Lane, C R Rizza, T J Snape
Developments in Biological Standardization
|
January 1, 1979
The assay of prekallikrein activator in human blood products
T J Snape, D Griffith, L Vallet, et al.
Transfusion
|
May 1, 1979
A factor VIII concentrate of intermediate purity and higher potency
J K Smith, D R Evans, V Stone, et al.
Journal of Clinical Pathology
|
October 1, 1980
Evaluation of an AutoAnalyzer method for quantitating anti-A and anti-B haemagglutinins in factor VIII preparations
P J Bowell, S Abdalla, T J Snape, et al.
SAR and QSAR in Environmental Research
|
August 22, 2023
Pteridine reductase (PTR1): initial structure-activity relationships studies of potential leishmanicidal arylindole derivatives compounds
J V Silva, S Sueyoshi, T J Snape, et al.
Environmental Technology
|
August 27, 2009
Versatility of a new bioinorganic catalyst: palladized cells of Desulfovibrio desulfuricans and application to dehalogenation of flame retardant materials
K Deplanche, T J Snape, S Hazrati, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Developments in Biological Standardization
|
January 1, 1979
Testing for potential thrombogenicity of prothrombin complex concentrates
T J Snape
Developments in Biological Standardization
|
January 1, 1987
Quality control in the development of coagulation factor concentrates
T J Snape
Current Medicinal Chemistry
|
July 27, 2012
2-Arylindoles: a privileged molecular scaffold with potent, broad-ranging pharmacological activity
S Lal, T J Snape
Vox Sanguinis
|
January 1, 1980
Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield
R T Wensley, T J Snape
British Journal of Haematology
|
August 1, 1975
A five year experience of the use of factor IX type DE(I) concentrate for the treatment of Christmas disease of Oxford
J L Lane, C R Rizza, T J Snape
Developments in Biological Standardization
|
January 1, 1979
The assay of prekallikrein activator in human blood products
T J Snape, D Griffith, L Vallet, et al.
Transfusion
|
May 1, 1979
A factor VIII concentrate of intermediate purity and higher potency
J K Smith, D R Evans, V Stone, et al.
Journal of Clinical Pathology
|
October 1, 1980
Evaluation of an AutoAnalyzer method for quantitating anti-A and anti-B haemagglutinins in factor VIII preparations
P J Bowell, S Abdalla, T J Snape, et al.
SAR and QSAR in Environmental Research
|
August 22, 2023
Pteridine reductase (PTR1): initial structure-activity relationships studies of potential leishmanicidal arylindole derivatives compounds
J V Silva, S Sueyoshi, T J Snape, et al.
Environmental Technology
|
August 27, 2009
Versatility of a new bioinorganic catalyst: palladized cells of Desulfovibrio desulfuricans and application to dehalogenation of flame retardant materials
K Deplanche, T J Snape, S Hazrati, et al.
Page
of 2